Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2

MLA

Hong-Su Park, et al. “Intranasal Immunization with Avian Paramyxovirus Type 3 Expressing SARS-CoV-2 Spike Protein Protects Hamsters against SARS-CoV-2.” Npj Vaccines, vol. 7, no. 1, June 2022, pp. 1–15. EBSCOhost, https://doi.org/10.1038/s41541-022-00493-x.

APA

Hong-Su Park, Yumiko Matsuoka, Cindy Luongo, Lijuan Yang, Celia Santos, Xueqiao Liu, Laura R. H. Ahlers, Ian N. Moore, Sharmin Afroz, Reed F. Johnson, Bernard A. P. Lafont, David W. Dorward, Elizabeth R. Fischer, Craig Martens, Siba K. Samal, Shirin Munir, Ursula J. Buchholz, & Cyril Le Nouën. (2022). Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2. Npj Vaccines, 7(1), 1–15. https://doi.org/10.1038/s41541-022-00493-x

Chicago

Hong-Su Park, Yumiko Matsuoka, Cindy Luongo, Lijuan Yang, Celia Santos, Xueqiao Liu, Laura R. H. Ahlers, et al. 2022. “Intranasal Immunization with Avian Paramyxovirus Type 3 Expressing SARS-CoV-2 Spike Protein Protects Hamsters against SARS-CoV-2.” Npj Vaccines 7 (1): 1–15. doi:10.1038/s41541-022-00493-x.